News
Curia signs license agreement with MilliporeSigma to support production of proteins and antibodiesALBANY, N.Y., June 20, 2023 (GLOBE NEWSWIRE) -- Curia, a leading contract research, development ...
The cell line development service global market is expected to reach $1,702.2 million by 2028 growing at a double digit CAGR from 2020 to 2028. Increasing demand for monoclonal antibodies ...
AMERSHAM, England, Oct. 6, 2022 /CNW/ -- Global life sciences leader Cytiva has acquired CEVEC Pharmaceuticals, a leading German provider of high-performance cell line development and viral vector ...
Cell line development is key for biopharmaceutical production, cancer research, drug screening and functional gene studies. In this webinar, you’ll learn how researchers from Stanford University and ...
Discover how to streamline your cell line development process for recombinant protein and monoclonal antibody production with this in-depth eBook. Whether you're working with CHO, HEK293, or ...
The cell line development market is growing at a CAGR of approximately 8-10% due to the increasing adoption of cell-based therapies. Key drivers include the rising demand for monoclonal antibodies, ...
Insourcing cell-line development has helped a fast-growing antibody manufacturer to deliver process improvements and strengthen communication with their contract manufacturer, according to Genmab ...
In this GEN webinar, Thibault Laurent, an expert in cell line development and genome engineering, shares a data-driven vision for the future of biologics production and discusses progress toward ...
Cellistic Launches Allo Chassis ™: Ready-to-use, immune-cloaked iPSC Cell Lines facilitating cost-effective cell therapy development February 17, 2025 08:00 AM Eastern Standard Time ...
ALBANY, N.Y., June 20, 2023 (GLOBE NEWSWIRE) — Curia, a leading contract research, development and manufacturing organization, today announced it has signed a licensing agreement with MilliporeSigma, ...
Cell line development is key for biopharmaceutical production, cancer research, drug screening and functional gene studies. In this webinar, you’ll learn how researchers from Stanford University and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results